Nouveau Life Pharmaceuticals, Inc.

OTC: NOUV · Industrials · Agricultural - Commodities/Milling

PublicHQ Ft. Lauderdale, FLReports USD

#889 of 976 Industrials companies by revenue

EA Score

——

FH —DQ —GM —SS 42

v0.1 · 5/100 weight · pillars only

↑ listing tenure, return on assets · ↓ Altman-Z, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$17.2k

Employees

—

as of 2026-08-28

Market cap

$90.0k

as of 2026-08-28

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02024

Net income-$17.2k-$17.2k2024

Operating income-$17.2k-$17.2k2024

Total assets$1.3M$1.3M2007

Liabilities$1.0M$1.0M2007

Equity$315.9k$315.9k2007

Revenue trend

FY2003 – FY2024 · USD

FY03

FY04

FY05

FY06

FY07

FY24

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Nouveau Life Pharmaceuticals, Inc.’s revenue?

Nouveau Life Pharmaceuticals, Inc. booked $0 in FY2024 revenue — among the slowest-growing Industrials companies we track, at a -Infinity% net margin.

Key facts

CEOBrian Shibley

SectorIndustrials

IndustryAgricultural - Commodities/Milling

HeadquartersFt. Lauderdale, FL

ExchangeOTC: NOUV

Employees—

IPO date2003-02-21

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.